Top 23 Biopharmaceutical companies based in South San Francisco, United States

“About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions.”

“Sutro Biopharma, Inc, is relentlessly focused on the discovery and development of precisely designed cancer therapeutics to transform what science can do for patients.”

“Formerly based in South San Francisco, California, Onyx Pharmaceuticals was engaged in the development and commercialization of innovative therapies for improving the lives of…”

“Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease.”

“At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.”

“RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory…”

“Septerna is on a mission to make the promise of future GPCR medicines a reality for patients.”

“NGM Bio is a biopharmaceutical company focused on discovering and developing novel, life-changing medicines for people whose health and lives have been disrupted by disease.”

“CytomX Therapeutics, Inc.”

“California Life Sciences (CLS) is the state’s most impactful life sciences membership organization, advocating for the sector and its diverse innovation pipeline.”

“Circle Pharma initiated operations in June 2014 with seed funding from Pfizer, Inc.”

“Star Therapeutics is a biotechnology company focused on the discovery and development of life-changing therapies for diseases with significant unmet need.”

“Our mission is to cure age-related disease by moving successful therapeutics toward clinical trials within months, not years.#CreatingTime”

“RemeGen Biosciences is a biopharmaceutical company, focusing on the discovery and development of innovative medicines for the treatment of cancer and autoimmune diseases, based in…”

“Lyterian Therapeutics derives its name from the Greek word λυτήριος or lutḗrios, that defines the termination, healing, or end of disease.”

“Moonwalk Biosciences is pioneering novel therapeutics in adipose biology and tissue, driven by deep genetic and epigenetic evidence and insights.”

“At Apertor we have developed a new class of therapeutics to address one of the toughest challenges in drug discovery, selective disruption of disease-causing protein-protein…”

“R2M Pharma is a fast growing biotechnology research organization devoted to the discovery of high quality small molecules preclinical development compounds for the treatment of…”

“LiVeritas Biosciences enables biopharma companies to fast track drug research & development (R&D) process through mass spectrometry (MS) and digital transformation.”

“Initial Therapeutics is discovering and developing a new class of small-molecule medicines designed to halt pathogenic protein formation in the earliest stages.”